Target Audience

The intended audience for the activity is ophthalmologists and other health care professionals involved in the treatment of patients with ocular disorders.

Learning Objectives: General Sessions

Upon successful completion of this activity, participants should be better able to:

  • Examine new techniques and technology in cataract surgery such as intraoperative imaging, IOL exchange and power calculations, and the use of accommodating, presbyopic, and light adjustable lens.
  • Review complex cases and complications management in cataract and refractive surgery.
  • Summarize practice pearls in premium and toric IOL implantation and state-of-the-science cataract surgical techniques and the latest evidence-based recommendations.
  • Evaluate state-of-the-science astigmatism management as it relates to preoperative measurements, corneal conditions, use of toric IOLs, limbal relaxing incisions, and enhancements.
  • Review the safety and efficacy of new pharmacologic agents approved for use in ophthalmic conditions and diseases.
  • Analyze the safety and efficacy of new or refined strategies for managing corneal health, including: evidence-based dosing regimens for anti-infective and anti-inflammatory drugs in cataract and refractive surgery and the rationale behind them, the latest advances in treating corneal disease, and the latest evidence on the treatment of dry eye and ocular allergy.
  • Evaluate new evidence on corneal-based and lens-based refractive surgery, including surface ablation, LASIK, SMILE, crosslinking, refractive indexing, and other innovations.
  • Assess new evidence and applications for the use of telemedicine, imaging, as well as the medical and surgical management of retinal vascular disorders.
  • Review the latest medical and surgical advances in glaucoma and their efficacy in reducing progression of disease.
  • Examine how new practice management services and shared decision-making approaches, integrated into the daily office flow, can better serve patients.

Learning Objectives: Sunday CME Seminar

Upon successful completion of this activity, participants should be better able to:

  • Examine injection protocols that have been shown to improve the long-term management of diabetic retinopathy and age-related macular degeneration.
  • Summarize how the persistence of retinal fluid post-treatment may influence visual outcomes in patients with retinal diseases.
This continuing medical education activity is provided by

OSN New York 2020 is supported, in part, by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

ACCREDITATION: Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to mitigate and disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.